Antengene
Antengene Corporation Limited, headquartered in China, is a pioneering biopharmaceutical company focused on the development and commercialisation of innovative therapies for cancer treatment. Founded in 2017, Antengene has rapidly established itself in the oncology sector, with a strong emphasis on precision medicine and targeted therapies. The company operates primarily in Asia-Pacific regions, aiming to address unmet medical needs through its robust pipeline of novel drug candidates. Antengene's core products include a range of innovative therapies that leverage cutting-edge technology, setting them apart in a competitive market. With notable achievements in clinical trials and strategic partnerships, Antengene is positioned as a key player in the biopharmaceutical industry, committed to improving patient outcomes and advancing cancer care globally.
DitchCarbon Score
How does Antengene's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Antengene's score of 22 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Antengene's reported carbon emissions
In 2023, Antengene, headquartered in China (CN), reported total carbon emissions of approximately 1,169,980 kg CO2e. This figure includes about 45,220 kg CO2e from Scope 1 emissions and approximately 1,124,760 kg CO2e from Scope 2 emissions. The company's emissions have shown fluctuations over the years. In 2022, total emissions were about 1,613,260 kg CO2e, with Scope 1 contributing approximately 551,320 kg CO2e and Scope 2 at around 1,061,940 kg CO2e. In 2021, emissions reached about 994,380 kg CO2e, while in 2020, they were approximately 278,470 kg CO2e. Despite these figures, Antengene has not publicly disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented reduction strategies suggests a need for further commitment to climate action within the industry context. As the company continues to grow, addressing carbon emissions will be crucial for aligning with global sustainability goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 27,080 | 00,000 | 000,000 | 00,000 |
| Scope 2 | 251,390 | 000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Antengene is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
